Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function.
Platelet and monocyte activation may contribute to hemolytic anemia, thrombocytopenia and renal failure associated with the hemolytic uremic syndrome (HUS) caused by Escherichia coli O157:H7. Since Shiga toxins (Stxs) and lipopolysaccharide (LPS) from this bacterium are implicated in the pathogenesis of HUS, we examined whether stimulation of THP-1 human monocytic cells by Shiga toxin 2 (Stx2) and LPS can lead to the activation of platelet function. We now show that Stx2 causedTHP-1 cells to release the chemokines IL-8, MDC, and RANTES and that the presence of LPS further stimulated this release. IL-8 was produced in greatest amount and was an effective co-agonist for inducing platelet aggregation. Primary human monocytes also released large amounts of IL-8 in response to LPS and Stx2. Factors released byTHP-1 cells exposed to Stx2 and LPS activated platelet function as evidenced by increased aggregation, serotonin secretion, P-selectin exposure and by the formation of stable platelet-monocyte aggregates. Our data therefore show that monocytes exposed to E.coli-derived Stx2 and LPS release factors which activate platelet function.
Guessous
Fadila
F
Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Marcinkiewicz
Marek
M
Polanowska-Grabowska
Renata
R
Keepers
Tiffany R
TR
Obrig
Tom
T
Gear
Adrian R L
AR
D001792:Blood Platelets / Q000502:physiology; D002450:Cell Communication / Q000502:physiology; D045744:Cell Line, Tumor; D054422:Chemokine CCL22; D018946:Chemokine CCL5 / Q000378:metabolism; D019742:Chemokines, CC / Q000378:metabolism; D003594:Cytoplasmic Granules / Q000502:physiology; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism; D007938:Leukemia; D008070:Lipopolysaccharides / Q000494:pharmacology*; D009000:Monocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D010974:Platelet Aggregation / Q000502:physiology*; D022641:Shiga Toxin 2 / Q000494:pharmacology*
C515482:CCL22 protein, human; D054422:Chemokine CCL22; D018946:Chemokine CCL5; D019742:Chemokines, CC; D016209:Interleukin-8; D008070:Lipopolysaccharides; D022641:Shiga Toxin 2